# Universe Pharmaceuticals Inc. (UPC)

Source: https://www.quantisnow.com/company/UPC
Generated: 2026-11-11T04:49:18.443Z

- Ticker: UPC
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2021
- SEC CIK: 0001809616
- Website: dzrzy.com

## About

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief for common chronic health conditions in the elderly for the physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'an, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.

## Latest UPC news and filings

- 2026-10-13 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-universe-pharmaceuticals-inc-6743867)
- 2026-10-06 20:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-6738872)
- 2026-09-29 20:11 UTC [SEC Form F-3 filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-f-3-filed-by-universe-pharmaceuticals-inc-6729248)
- 2026-09-03 20:31 UTC [SEC Form 6-K] [Amendment: SEC Form 6-K/A filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-6-ka-filed-by-universe-pharmaceuticals-inc-6705345)
- 2026-09-01 21:25 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-6701827)
- 2026-07-31 20:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-6657758)
- 2026-07-29 20:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-6653617)
- 2026-06-29 13:50 UTC [4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones](https://www.quantisnow.com/insight/4-sizzling-biotech-and-healthcare-companies-reporting-strategic-milestones-6618579)
- 2026-06-26 20:06 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-6617285)
- 2026-06-26 20:05 UTC [Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio](https://www.quantisnow.com/insight/universe-pharmaceuticals-inc-announces-strategic-acquisition-to-expand-pharmaceutical-patent-6617247)
- 2026-05-21 20:16 UTC [SEC Form 4] [Chief Executive Officer Lai Gang was granted 71,890 units of Class A ordinary shares and was granted 12,610 units of Class B ordinary shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-lai-gang-was-granted-71890-units-of-6567541)
- 2026-05-14 20:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-6553946)
- 2026-04-16 20:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-6503197)
- 2026-03-18 12:27 UTC [SEC Form 3] [SEC Form 3 filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-3-filed-by-universe-pharmaceuticals-inc-6455503)
- 2026-03-18 12:25 UTC [SEC Form 3] [SEC Form 3 filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-3-filed-by-universe-pharmaceuticals-inc-6455484)
- 2026-03-18 12:20 UTC [SEC Form 3] [SEC Form 3 filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-3-filed-by-universe-pharmaceuticals-inc-6455481)
- 2026-03-18 12:22 UTC [SEC Form 3] [SEC Form 3 filed by new insider Yang Lin (Lydia)](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-yang-lin-lydia-6455470)
- 2026-03-18 12:26 UTC [SEC Form 3] [SEC Form 3 filed by new insider Lai Gang](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-lai-gang-6455455)
- 2026-03-18 12:23 UTC [SEC Form 3] [SEC Form 3 filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-3-filed-by-universe-pharmaceuticals-inc-6455411)
- 2026-02-11 21:06 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-6386572)
- 2026-02-11 21:05 UTC [Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure](https://www.quantisnow.com/insight/universe-pharmaceuticals-inc-announces-effective-date-of-dual-class-share-structure-6386486)
- 2026-01-29 00:34 UTC [SEC Form 20-F filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-20-f-filed-by-universe-pharmaceuticals-inc-6364837)
- 2026-01-07 20:37 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-universe-pharmaceuticals-inc-6340928)
- 2025-09-03 20:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-6187934)
- 2025-08-26 20:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-6179153)
- 2025-07-29 20:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-6136475)
- 2025-07-03 20:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-6110896)
- 2025-05-15 22:07 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-universe-pharmaceuticals-inc-6043915)
- 2025-04-29 20:05 UTC [SEC Form 20-F filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-20-f-filed-by-universe-pharmaceuticals-inc-6007153)
- 2025-03-20 12:33 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-5953683)
- 2025-03-20 12:30 UTC [Universe Pharmaceuticals INC Announces Share Consolidation](https://www.quantisnow.com/insight/universe-pharmaceuticals-inc-announces-share-consolidation-5953645)
- 2025-03-11 20:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-5938227)
- 2025-03-03 21:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-5920148)
- 2025-02-25 21:11 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-5908249)
- 2025-02-25 21:10 UTC [Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report](https://www.quantisnow.com/insight/universe-pharmaceuticals-inc-receives-staff-determination-notice-from-nasdaq-related-5908199)
- 2025-02-20 21:05 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-5900122)
- 2025-02-18 21:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-5893658)
- 2025-02-14 22:24 UTC [SEC Form SCHEDULE 13G filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-universe-pharmaceuticals-inc-5891813)
- 2025-02-11 21:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-5881991)
- 2025-02-03 21:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Universe Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-universe-pharmaceuticals-inc-5867347)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/UPC
- Earnings history: https://www.quantisnow.com/earnings/UPC
- Dividend history: https://www.quantisnow.com/dividends/UPC
- Insider transactions: https://www.quantisnow.com/insiders/UPC
- Options chain: https://www.quantisnow.com/options/UPC
- SEC 8-K filings only: https://www.quantisnow.com/company/UPC/8-k
- RSS and alerts for UPC: https://www.quantisnow.com/docs/rss-feeds.md